The significance of the number of CGG repeats and autoantibodies in premature ovarian failure  Cem Fıçıcıoglu, Gazi Yildirim, Rukset Attar, Banu Kumbak,

Slides:



Advertisements
Similar presentations
Development of guideline-based quality indicators for recurrent miscarriage E. van den Boogaard, M. Goddijn, N.J. Leschot, F. van der Veen, J.A.M. Kremer,
Advertisements

L. M. Moolenaar, M. Connolly, B. Huisman, M. J. Postma, P. G. A
Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis  Sesh Kamal Sunkara, Jyotsna Pundir,
Programmes and prospects for ovotechnology
Kathryn J. Woad, Deborah Prendergast, Ingrid M. Winship, Andrew N
Attitudes and policies regarding access to fertility care and assisted reproductive technologies in Israel  Daniel Sperling, Yael Simon  Reproductive.
Vuong Thi Ngoc Lan, Nguyen Khanh Linh, Ho Manh Tuong, P. C
Diet and endometriosis risk: A literature review
Fresh and cryopreserved ovary transplantation and resting follicle recruitment  Sherman Silber, Jorge Pineda, Kathleen Lenahan, Michael DeRosa, Jeffrey.
FMR1 gene CGG repeat variation within the normal range is not predictive of ovarian response in IVF cycles  Scott J. Morin, Ashley W. Tiegs, Jason M.
Hatem Abu Hashim  Reproductive BioMedicine Online 
Norbert Gleicher, Andrea Weghofer, David H. Barad 
Protective effect of resveratrol against oxidative damage to ovarian reserve in female Sprague–Dawley rats  Pınar Özcan, Cem Fıçıcıoğlu, Özge Kızılkale.
E. Jauniaux, I. Ben-Ami, R. Maymon  Reproductive BioMedicine Online 
Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction  Antonio La Marca, Giovanni D’Ippolito 
Advanced glycation end product concentrations in follicular fluid of women undergoing IVF/ICSI with a GnRH agonist protocol  Qi Yao, Yuanjiao Liang, Yong.
Intra-cycle fluctuations of anti-Müllerian hormone in normal women with a regular cycle: a re-analysis  Annelies Overbeek, Frank J. Broekmans, Wouter.
E. Jauniaux, I. Ben-Ami, R. Maymon  Reproductive BioMedicine Online 
Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist- treated oocyte donors  Nikolaos P. Polyzos, Dominic Stoop, Christophe.
A. La Marca, G. Sighinolfi, S. Giulini, M. Traglia, C. Argento, C
L. L. van Loendersloot, M. van Wely, S. Repping, F. van der Veen, P. M
Gillian M. Lockwood  Reproductive BioMedicine Online 
Aspirin and heparin as adjuvants during IVF do not improve live birth rates in unexplained implantation failure  Muhammad A. Akhtar, Hanan Eljabu, James.
Anti-Müllerian hormone as a predictor of pregnancy following IVF
Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles  Reshef Tal, David B. Seifer, Moisey Khanimov, Eliana.
Sherman Silber  Reproductive BioMedicine Online 
Why are reproductive cancers more common in nulliparous women?
K. Gersak, A. Veble  Reproductive BioMedicine Online 
Consecutive repeat miscarriages are likely to occur in the same gestational period  Junhao Yan, Sotirios H. Saravelos, Ning Ma, Caihong Ma, Zi-Jiang Chen,
Utility of age-specific serum anti-Müllerian hormone concentrations
What’s on the mind of IVF consumers?
S Munné, E Fragouli, P Colls, MG Katz-Jaffe, WB Schoolcraft, D Wells 
Sarah McCredie, William Ledger, Christos A. Venetis 
Effect of N-acetyl-cysteine after ovarian drilling in clomiphene citrate-resistant PCOS women: a pilot study  A. Nasr  Reproductive BioMedicine Online 
Cumulative live-birth delivery after IVF/ICSI since the progressive introduction of single- embryo transfer  D. De Neubourg, C. Daels, M. Elseviers, K.
Effect of energy expenditure and physical activity on the outcomes of assisted reproduction treatment  Mert Kucuk, Fadime Doymaz, Bulent Urman  Reproductive.
Ovarian reserve determinations suggest new function of FMR1 (fragile X gene) in regulating ovarian ageing  Norbert Gleicher, Andrea Weghofer, David H.
M. Dieterich, M. Bolz, T. Reimer, S. Costagliola, B. Gerber 
Anti-Müllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF/ICSI cycles: a prospective, multi-centre, observational.
Cross-border reproductive care: a review of the literature
Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial  Vivian Chi Yan Lee, Carina Chi Wai Chan,
Myotonic dystrophy type 1 and PGD: ovarian stimulation response and correlation analysis between ovarian reserve and genotype  C. Dechanet, C. Castelli,
The relationship between sperm head retardance using polarized light microscopy and clinical outcomes  Belinda G. Vermey, Michael G. Chapman, Simon Cooke,
Dehydroepiandrostendione sulphate and prediction of live birth after IVF in young women with low anti-Müllerian hormone concentration  Miro Šimun Alebić,
Impact of vitamin D levels on ovarian reserve and ovarian response to ovarian stimulation in oocyte donors  Alberta Maria Fabris, Maria Cruz, Carlos Iglesias,
V Isachenko, E Isachenko, R Kreienberg, M Woriedh, JM Weiss 
Swapna S. Desai, Swati K. Achrekar, Smita R. Paranjape, Sadhana K
The value of HCG serum concentrations after trigger in predicting pregnancy and live birth rates in IVF–ICSI  Jianjun Zhou, Shanshan Wang, Bin Wang, Junxia.
Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management – meta-analyses  Daniele Santi, Giorgia.
Should we be promoting embryo transfer at blastocyst stage?
Stephen C. Collins, Esther Chan  Reproductive BioMedicine Online 
Pietro Gambadauro, Ramesan Navaratnarajah 
Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature  Micah J. Hill, Gary Levy, Eric D. Levens 
Genome-wide analysis shows no genomic predictors of ovarian response to stimulation by exogenous FSH for IVF  Jeroen van Disseldorp, Lude Franke, Rene.
Jeff G. Wang, Nataki C. Douglas, Gary S. Nakhuda, Janet M
The Alpha Consensus Meeting on the professional status of the clinical embryologist: proceedings of an expert meeting    Reproductive BioMedicine Online 
A. La Marca, S. M. Nelson, G. Sighinolfi, M. Manno, E. Baraldi, L
Predictive value of ovarian reserve markers in smoking and non-smoking women undergoing IVF  Thomas Freour, Lionel Dessolle, Miguel Jean, Damien Masson,
Ovarian reserve screening before contraception?
Comparative incidence of ovarian hyperstimulation syndrome following ovarian stimulation with corifollitropin alfa or recombinant FSH  Basil C. Tarlatzis,
Programmes and prospects for ovotechnology
Limitations of a time-lapse blastocyst prediction model: a large multicentre outcome analysis  Kirstine Kirkegaard, Alison Campbell, Inge Agerholm, Ursula.
Claudio Manna, Loris Nanni, Alessandra Lumini, Sebastiana Pappalardo 
Randomized controlled trial of benzocaine versus placebo spray for pain relief at hysterosalpingogram  E.A. Bachman, S. Senapati, M.D. Sammel, S.K. Kalra 
Does theFMR1 gene affect IVF success?
China’s model of egg donation is a policy lesson for Britain
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
M. Franz, J. Ott, A. Watrelot, L. Küssel, H. Husslein 
Fertility in cancer patients after cryopreservation of one ovary
Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era?  Antonio La Marca, Martina Capuzzo  Reproductive.
Presentation transcript:

The significance of the number of CGG repeats and autoantibodies in premature ovarian failure  Cem Fıçıcıoglu, Gazi Yildirim, Rukset Attar, Banu Kumbak, Narter Yesildaglar  Reproductive BioMedicine Online  Volume 20, Issue 6, Pages 776-782 (June 2010) DOI: 10.1016/j.rbmo.2010.02.011 Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

Figure 1 The receiver operating characteristic (ROC) curve for ovarian reserve parameters in premature ovarian senescence (in both premature ovarian ageing and premature ovarian failure). AMH=anti-Müllerian hormone. Reproductive BioMedicine Online 2010 20, 776-782DOI: (10.1016/j.rbmo.2010.02.011) Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

Figure 2 The relationship of anti-Müllerian hormone (AMH) with (A) FSH and (B) allele 1. Reproductive BioMedicine Online 2010 20, 776-782DOI: (10.1016/j.rbmo.2010.02.011) Copyright © 2010 Reproductive Healthcare Ltd. Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.